Records documenting symptoms, diagnosis, treatment history, and the timing of medication use can help establish whether complications developed after exposure to semaglutide or tirzepatide medications
These GLP-1 lawsuits claim that drug manufacturers failed to adequately warn consumers and healthcare providers about the heightened risk of severe gastrointestinal injuries, stomach paralysis, permanent vision loss, and other serious health complications
They cannot replace healthy lifestyle habits which forms the core of any diabetes management or weight loss program
Conversely, certain FTO variants suggest metabolic flexibility that may benefit from combined behavioral and pharmacological strategies
For cardiovascular benefits, the timeline extends further
The WeightWatchers GLP-1 Program, all within the WeightWatchers App, to complement their journey on a GLP-1 medication, if deemed appropriate